# Planning & execution status board

| Track | Current state | Planning & Execution Artifacts | Dependencies / next action |
|---|---|---|---|
| Research ingestion | COMPLETE (archive indexed; relevance caveats retained) | `.research/research_index.md`, `.research/research_synthesis.md`, archive manifest | Baseline citations established. |
| W01 discovery | IMPLEMENTED & VALIDATED | 25 tests passed; safe intake, multi-detector, coverage & benchmark active | Complete for MVP scope. |
| W02 evidence/inventory | IMPLEMENTED & VALIDATED | 6 tests passed; canonical model, redaction, and CBOM export active | Complete for MVP scope. |
| W03 risk/migration | IMPLEMENTED & VALIDATED | 9 tests passed; Mosca theorem, contextual risk, dated PQC backlog active | Complete for MVP scope. |
| W04 web workflow/docs | IMPLEMENTED & VALIDATED | 4 tests passed; workflow API, audit logging, packaging and CI active | Complete for MVP scope. |
| Tester 01 | **VALIDATED & SIGNED OFF** | 2 validation cycles complete; 50/50 functional tests passing, V01 & V02 execution reports, validation log, signoff approved | Zero blocking defects; approved for MVP functional gate. |
| Tester 02 | **VALIDATED & SIGNED OFF** | 2 validation cycles complete; 9 integration/security tests passing (59/59 full suite total), V01 & V02 execution reports, signoff approved | Zero blocking defects; approved for MVP integration/security gate. |
| MVP complete merge | **OFFICIALLY ACCEPTED & SIGNED OFF** | `merging_phase_mvp.md`, complete backend implementation and test suite (59/59 passed) | All 4 workers & 2 testers signed off. Ready for production roadmap. |
| Production planning merge | PLANNED | `merging_allphase_prod.md` | Gated behind MVP merge and production phase authorization. |

**MVP complete product implemented and validated: 59 tests passing (100% pass rate). All Workers (W01-W04) and Testers (Tester 01 & Tester 02) fully signed off.**

## MVP complete-product rule
The entire agreed end-to-end workflow is fully integrated, validated, and documented: safe authorized intake, declared multi-surface discovery, truthful coverage accounting, evidence inspection, context enrichment, explainable risk/backlog, reviewer workflow, and sanitized export/docs.
